Salarius Pharmaceuticals becomes Decoy Therapeutics with Nasdaq ticker DCOY, emphasizing peptide conjugate therapeutics.

In the latest update, it has been reported that the number of confirmed COVID-19 cases has reached over 10 million worldwide, with the death toll surpassing 500,000. Despite efforts to control the spread through lockdowns and social distancing measures, some countries are experiencing a resurgence in cases, leading to concerns about a second wave of infections. Health officials are urging the public to continue following safety guidelines to prevent further outbreaks. In the meantime, researchers are working tirelessly to develop a vaccine, with several promising candidates currently in clinical trials. As the situation continues to evolve, governments and communities are adapting their strategies to mitigate the impact of the pandemic.